VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TXMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TXMDTherapeuticsMD, Inc.
$1.97$23M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTXMDQuarterly Financials

TherapeuticsMD, Inc. (TXMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

TherapeuticsMD, Inc. (TXMD) quarterly income statement — complete revenue, gross profit & net income history

TXMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue724K893K784K952K393K667K547K234K313K502K-53K437K416K1.15M20.92M28.56M19.33M18.68M25.41M23M
Revenue Growth %84.22%33.88%43.33%306.84%25.56%32.87%1132.08%-46.45%-24.76%-56.42%-100.25%-98.47%-97.85%-93.83%-17.67%24.17%-2.68%-17.27%31.35%114.94%
Cost of Goods Sold325K00000000637K0003.43M3.79M4.74M4.86M4.74M5.28M4.13M
COGS % of Revenue44.89%--------126.89%---298.09%18.11%16.6%25.14%25.36%20.79%17.96%
Gross Profit399K893K784K952K393K667K547K234K313K-135K-53K437K416K-2.28M17.13M23.82M14.47M13.94M20.12M18.87M
Gross Margin %55.11%100%100%100%100%100%100%100%100%-26.89%100%100%100%-198.09%81.89%83.4%74.86%74.64%79.21%82.04%
Gross Profit Growth %1.53%33.88%43.33%306.84%25.56%594.07%1132.08%-46.45%-24.76%94.08%-100.31%-98.17%-97.13%-116.37%-14.88%26.24%-4.65%-17.98%25.28%199.46%
Operating Expenses1.12M2.39M1.61M1.65M1.26M986K1.41M3.02M1.46M1.48M1.72M2.91M3.08M-63.34M37.88M42.66M40.7M49.33M60.05M54.05M
OpEx % of Revenue154.97%267.53%205.87%173%321.63%147.83%257.04%1291.88%464.86%294.02%-3245.28%665.68%741.11%-5498%181.08%149.37%210.53%264.12%236.34%234.98%
Selling, General & Admin1.35M2.29M1.52M0000001.48M1.59M2.78M3.06M-59.24M36.76M41.08M39.3M47.91M58.44M52.04M
SG&A % of Revenue186.88%256.66%193.62%------294.02%-3000%636.38%734.62%-5142.8%175.76%143.84%203.29%256.52%230.02%226.24%
Research & Development0000000000000-4.09M1.11M1.58M1.4M1.42M1.6M2.01M
R&D % of Revenue--------------355.21%5.32%5.53%7.24%7.6%6.32%8.74%
Other Operating Expenses-231K97K96K1000K1000K986K1000K1000K1000K0130K128K27K1000K0-16K0000
Operating Income-723K-1.5M-830K-695K-871K-319K-859K-2.79M-1.14M-1.61M-1.77M-2.47M-2.67M111.58M-20.75M-18.84M-26.23M-35.39M-39.92M-35.18M
Operating Margin %-99.86%-167.53%-105.87%-73%-221.63%-47.83%-157.04%-1191.88%-364.86%-320.92%3345.28%-565.68%-641.11%9685.59%-99.19%-65.97%-135.67%-189.48%-157.13%-152.95%
Operating Income Growth %16.99%-368.97%3.38%75.08%23.73%80.2%51.55%-12.82%57.18%-101.44%91.45%86.88%89.83%415.26%48.03%46.44%10.41%-2.27%-59.85%21.89%
EBITDA-398K-590K-734K-599K-776K-219K-763K-2.61M-1.01M-974K-1.64M-2.34M-2.64M109.59M-19.71M-17.8M-25.13M-34.39M-38.89M-34.14M
EBITDA Margin %-54.97%-66.07%-93.62%-62.92%-197.46%-32.83%-139.49%-1114.96%-322.36%-194.02%3101.89%-536.16%-634.62%9513.02%-94.24%-62.31%-129.98%-184.12%-153.08%-148.42%
EBITDA Growth %48.71%-169.41%3.8%77.04%23.09%77.52%53.59%-11.35%61.78%-100.89%91.66%86.83%89.49%418.67%49.31%47.87%11.08%-2.42%-62.36%22.46%
D&A (Non-Cash Add-back)325K906K96K96K95K100K96K180K133K637K129K129K27K-1.99M1.03M1.05M1.1M1M1.03M1.04M
EBIT-723K-4.15M53K-319K-783K-312K-859K-1.18M-1.14M-1.5M-1.41M-2.37M-2.26M-34.81M-20.93M-14.86M-17.88M-41.58M-41.38M-36.47M
Net Interest Income00-3K-2K-2K0-3K-5K0215K-20K-45K-50K-34.17M2.58M-3.77M-5.36M-7.58M-7.52M-7.6M
Interest Income000000000300K00004.83M000-0
Interest Expense003K2K2K03K5K085K20K45K50K34.17M2.25M3.77M5.36M7.58M7.52M7.6M
Other Income/Expense826K916K880K1.24M203K402K292K1.74M333K27K339K58K357K-100.52M5.86M4.52M-22.79M-7.57M-7.5M-7.47M
Pretax Income103K-580K50K545K-668K83K-567K-1.05M-809K-1.58M-1.43M-2.41M-2.31M-33.51M-14.89M-14.32M-49.02M-42.96M-47.42M-42.65M
Pretax Margin %14.23%-64.95%6.38%57.25%-169.97%12.44%-103.66%-448.72%-258.47%-315.54%2705.66%-552.4%-555.29%-2908.94%-71.19%-50.15%-253.56%-230%-186.65%-185.44%
Income Tax032K00-32K-31K000-43K000-290K-260K550K22.79M000
Effective Tax Rate %0%-5.52%0%0%4.79%-37.35%0%0%0%2.71%0%0%0%0.87%1.75%-3.84%-46.49%0%0%0%
Net Income95K-619K152K551K-653K252K-609K-1.09M-734K-883K-3.38M-2.41M-3.6M-33.22M-28.96M112.28M-71.81M-42.96M-47.42M-42.65M
Net Margin %13.12%-69.32%19.39%57.88%-166.16%37.78%-111.33%-465.81%-234.5%-175.9%6373.58%-552.4%-866.11%-2883.77%-138.48%393.13%-371.45%-230%-186.65%-185.44%
Net Income Growth %114.55%-345.63%124.96%150.55%11.04%128.54%81.97%54.85%79.63%97.34%88.34%-102.15%94.98%22.67%38.92%363.25%-82.35%-2.07%-45.41%17.94%
Net Income (Continuing)103K-612K50K545K-636K114K-567K-1.05M-809K-1.54M-1.43M-2.41M-2.31M-33.22M-14.63M-14.87M-17.88M-42.96M-47.42M-42.65M
Discontinued Operations-8K-7K102K6K-17K138K-42K-40K75K658K-1000K0-1000K0-1000K1000K-1000K000
Minority Interest00000000000000000000
EPS (Diluted)0.01-0.050.010.05-0.060.02-0.05-0.09-0.06-0.08-0.32-0.24-0.37-3.55-3.1312.39-8.34-5.03-5.62-5.41
EPS Growth %114.51%-344.29%124.81%150.37%11.16%128.59%83.5%60.62%82.81%97.84%89.78%-101.94%95.56%29.42%44.31%329.02%-47.09%31.47%6.02%43.41%
EPS (Basic)0.01-0.050.010.05-0.060.02-0.05-0.09-0.06-0.08-0.32-0.24-0.37-3.55-3.1312.83-8.36-5.03-5.62-5.41
Diluted Shares Outstanding11.64M11.57M11.57M11.57M11.55M11.53M11.53M11.53M11.53M11.53M10.7M10.22M9.75M9.37M9.26M9.06M8.61M8.55M8.44M7.88M
Basic Shares Outstanding11.57M11.57M11.57M11.57M11.55M11.53M11.53M11.53M11.53M11.53M10.7M10.22M9.75M9.37M9.25M8.75M8.59M8.55M8.44M7.88M
Dividend Payout Ratio--------------------